Cargando…
Neuromodulation devices for heart failure( )
Autonomic imbalance with a sympathetic dominance is acknowledged to be a critical determinant of the pathophysiology of chronic heart failure with reduced ejection fraction (HFrEF), regardless of the etiology. Consequently, therapeutic interventions directly targeting the cardiac autonomic nervous s...
Autores principales: | Dusi, Veronica, Angelini, Filippo, Zile, Michael R, De Ferrari, Gaetano Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385122/ https://www.ncbi.nlm.nih.gov/pubmed/35991619 http://dx.doi.org/10.1093/eurheartjsupp/suac036 |
Ejemplares similares
-
Neuromodulation in heart failure( )
por: Zannad, Faiez
Publicado: (2022) -
Current and future use of neuromodulation in heart failure( )
por: Duncker, David, et al.
Publicado: (2022) -
Sympathetic activation in heart failure( )
por: Gronda, E, et al.
Publicado: (2022) -
Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata
por: Stolfo, Davide, et al.
Publicado: (2022) -
Evaluation of high‐sensitivity C‐reactive protein and uric acid in vericiguat‐treated patients with heart failure with reduced ejection fraction
por: Kramer, Frank, et al.
Publicado: (2020)